Unity Biotechnology (NASDAQ:UBX) Given “Neutral” Rating at HC Wainwright
Unity Biotechnology (NASDAQ:UBX – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday, Marketbeat reports. They presently have a $2.00 price objective on the stock, down from their previous price objective of $4.00. HC Wainwright’s target price points to a […]
Unity Biotechnology (NASDAQ:UBX – Get Free Report)‘s stock had its “neutral” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday, Marketbeat reports. They presently have a $2.00 price objective on the stock, down from their previous price objective of $4.00. HC Wainwright’s target price points to a […]
